AS Latvijas Juras medicinas centrs Cash Flow Conversion Efficiency
AS Latvijas Juras medicinas centrs cash flow conversion efficiency. Based on the latest financial reports, AS Latvijas Juras medicinas centrs (UOM) has a cash flow conversion efficiency ratio of -0.098x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-622.30K ≈ $-727.54K USD) by net assets (€6.33 Million ≈ $7.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of AS Latvijas Juras medicinas centrs (2015–2025)
Cash flow conversion efficiency of AS Latvijas Juras medicinas centrs from 2015 to 2025. This chart illustrates how AS Latvijas Juras medicinas centrs's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AS Latvijas Juras medicinas centrs stock quote for real-time trading data and today's change.
AS Latvijas Juras medicinas centrs Cash Flow Conversion Ratio Explained
AS Latvijas Juras medicinas centrs cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
AS Latvijas Juras medicinas centrs Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AS Latvijas Juras medicinas centrs ranked by their cash flow conversion efficiency. Also see market cap of AS Latvijas Juras medicinas centrs for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rebosis
JSE:REB
|
-0.010x |
|
Wa Kaolin Ltd
AU:WAK
|
-0.953x |
|
Prime Dividend Corp
TO:PDV
|
0.094x |
|
Nordic Mining ASA
OL:NOM
|
-0.198x |
|
Straker Ltd
AU:STG
|
-0.422x |
|
Xref Ltd
AU:XF1
|
-0.317x |
|
UNITEDLABELS Aktiengesellschaft
F:ULC
|
0.048x |
|
Speedvalue Ltd
TA:SPDV
|
0.085x |
Annual Cash Flow Conversion Efficiency for AS Latvijas Juras medicinas centrs (2015–2025)
The table below shows the annual cash flow conversion efficiency of AS Latvijas Juras medicinas centrs from 2015 to 2025. Review AS Latvijas Juras medicinas centrs free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €6.33 Million ≈ $7.40 Million |
€-17.28K ≈ $-20.20K |
-0.003x | -102.78% |
| 2024-12-31 | €6.17 Million ≈ $7.21 Million |
€605.02K ≈ $707.33K |
0.098x | -68.18% |
| 2023-12-31 | €6.20 Million ≈ $7.25 Million |
€1.91 Million ≈ $2.24 Million |
0.308x | +91.95% |
| 2022-12-31 | €6.81 Million ≈ $7.96 Million |
€1.09 Million ≈ $1.28 Million |
0.161x | +143.58% |
| 2021-12-31 | €6.34 Million ≈ $7.41 Million |
€418.24K ≈ $488.96K |
0.066x | -50.34% |
| 2020-12-31 | €5.52 Million ≈ $6.45 Million |
€732.71K ≈ $856.61K |
0.133x | +77.02% |
| 2019-12-31 | €5.50 Million ≈ $6.43 Million |
€412.86K ≈ $482.67K |
0.075x | -30.76% |
| 2018-12-31 | €5.53 Million ≈ $6.47 Million |
€599.57K ≈ $700.96K |
0.108x | +34.95% |
| 2017-12-31 | €5.96 Million ≈ $6.96 Million |
€478.41K ≈ $559.31K |
0.080x | +33.84% |
| 2016-12-31 | €6.97 Million ≈ $8.15 Million |
€418.49K ≈ $489.26K |
0.060x | +17.88% |
| 2015-12-31 | €7.12 Million ≈ $8.32 Million |
€362.36K ≈ $423.63K |
0.051x | -- |
About AS Latvijas Juras medicinas centrs
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more